177Lu-PP-F11N for Receptor Targeted Therapy and Imaging of Metastatic Thyroid Cancer. | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
177Lu-PP-F11N for Receptor Targeted Therapy and Imaging of Metastatic Thyroid Cancer.	Carcinoma, Medullary, Neoplasms by Histologic Type, Neoplasms, Ductal, Lobular, and Medullary, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Thyroid cancer, medullary, adenocarcinoma, carcinoma, epithelial neoplasm, neoplasm, neuroendocrine carcinoma, neuroendocrine neoplasm, primitive neuroectodermal tumor	Active, not recruiting	Phase 1	2026-05-01		NCT02088645

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Center for Proton Therapy, Paul Scherrer Institute, Villigen,Switzerland	2
Krebsforschung Schweiz, Bern, Switzerland	7
University Hospital Freiburg	38
University Hospital, Basel, Switzerland	243
University Hospital, Zürich	50

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
University Hospital Basel, Clinic for radiology and nuclear medicine	Basel	Switzerland	1